First Time Loading...
C

Codex DNA Inc
NASDAQ:DNAY

Watchlist Manager
Codex DNA Inc
NASDAQ:DNAY
Watchlist
Price: 2 USD 8.11% Market Closed
Updated: May 4, 2024

Codex DNA Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Codex DNA Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Codex DNA Inc
NASDAQ:DNAY
Operating Income
-$46.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Codex DNA Inc's Operating Income?
Operating Income
-46.5m USD

Based on the financial report for Dec 31, 2022, Codex DNA Inc's Operating Income amounts to -46.5m USD.

What is Codex DNA Inc's Operating Income growth rate?
Operating Income CAGR 1Y
-31%

Over the last year, the Operating Income growth was -31%.